3.0704
Xenetic Biosciences Inc Azioni (XBIO) Dati Finanziari
Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
Durata del periodo | 3 mesi | 3 mesi | 3 mesi | 3 mesi | 3 mesi |
Revenues |
0.57%
0.5899
|
0.5933 | 0.6488 | 0.6142 | 0.7264 |
|
14.41%
1.3143
|
1.5357 | 1.748 | 1.1137 | 2.0638 |
Benefits Costs and Expenses |
-
|
- | - | - | - |
Costs And Expenses |
14.41%
1.3143
|
1.5357 | 1.748 | 1.1137 | 2.0638 |
Provision For Loan, Lease, And Other Losses |
-
|
- | - | - | - |
Operating Income/Loss |
23.13%
-0.7244
|
-0.9424 | -1.0991 | -0.4995 | -1.3374 |
Net Interest Income/Expense |
12.65%
0.0342
|
0.0392 | 0.0519 | 0.0613 | 0.0634 |
Nonoperating Income/Loss |
9.06%
0.0357
|
0.0393 | 0.0446 | 0.0628 | 0.0634 |
Income/Loss From Continuing Operations Before Tax |
0.57%
0.5899
|
0.5933 | 0.6488 | 0.6142 | 0.7264 |
Income Tax Expense/Benefit |
-
|
- | - | - | - |
Income/Loss From Continuing Operations After Tax |
23.74%
-0.6887
|
-0.9031 | -1.0545 | -0.4367 | -1.274 |
|
23.74%
-0.6887
|
-0.9031 | -1.0545 | -0.4367 | -1.274 |
Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
Basic Average Shares |
0.00%
1.5421
|
1.5421 | 0.000269 | 1.5417 | 1.5408 |
Diluted Average Shares |
0.00%
1.5421
|
1.5421 | 0.000269 | 1.5417 | 1.5408 |
Basic Earnings Per Share |
23.73%
-0.45
|
-0.59 | -0.68 | -0.28 | -0.83 |
Diluted Earnings Per Share |
23.73%
-0.45
|
-0.59 | -0.68 | -0.28 | -0.83 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):